Nevertheless, VEGF/VEGF receptor inhibition by virtue of normalizing tumor vessels and alleviating innate immune suppression enhances intra-tumoral T cell function and may act in synergy with checkpoint inhibitors in primary and metastatic tumors [20,91]. The gene discussed is VEGFA; the disease is neoplasm.